News for hackers. Stuff that matters.
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by bawolff on Sunday September 08, 2024 @05:42PM (#41483475)
I think the main worry is scam artists who essentially pray on desperate people with "cures" that do nothing at best and shorten their lives at worse.

I'm fine with letting people try whatever they want if there are no other options (their life, although informed consent is tricky) however i dont think we should allow marketing such things to patients or allow anyone making money off it.

Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by Loughla on Sunday September 08, 2024 @10:02PM (#41484879)
Exactly. They should be able to take whatever experimental drugs might be available.

The problem is, how do companies identify these patients or how do patients identify these companies without leaving room for massive abuse.

Maybe the treatments have to be zero cost? That feels like it would eliminate all bad actors?

Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by BriggyDwiggs42 on Wednesday September 11, 2024 @02:16PM (#41513910)
That’s actually kinda a great idea imo
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by ALittleLight on Monday September 09, 2024 @03:26AM (#41486215)
There are already plenty of people who promote scam cures. We shouldn't deny potentially useful treatments to patients in dire need just to reduce somewhat the business of scammers.

Detect and punish scammers if they are an issue. Allow people to take risky medical treatments if they have serious incurable illnesses.

Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by XorNot on Monday September 09, 2024 @03:42AM (#41486294)
You're not adding money to the mix.

If a company or research group wants to sponsor an experimental treatment with patient approval and waiver free of charge, that's one thing.

But they almost immediately turn around and say " oh we'll need to cover costs..." and suddenly the incentive is very different.